Journal Article

Current Approaches to the Management of Sentinel Node Procedures in Early Vulvar Cancer in Germany: A Web-Based Nationwide Analysis of Practices

Weikel, Wolfgang, Peters, Katharina, Heimes, Anne-Sophie, Hamoud, Bashar Haj, Anic, Katharina, Schmidt, Mona W., Linz, Valerie C., Almstedt, Katrin, van der Ven, Josche, Battista, Marco J., Hasenburg, Annette, Dannecker, Christian, Bührer, Theresa-Louise, Stewen, Kathrin, Schwab, Roxana, Krajnak, Slavomir, Brenner, Walburgis

2023

Overview

Background: Lymph node involvement is the most important prognostic factor for recurrence and survival in vulvar cancer. Sentinel node (SN) procedure can be offered in well-selected patients with early vulvar cancer. This study aimed to assess current management practices with respect to the sentinel node procedure in women with early vulvar cancer in Germany. Methods: A Web-based survey was conducted. Questionnaires were e-mailed to 612 gynecology departments. Data were summarized as frequencies and analyzed using the chi-square test. Results: A total of 222 hospitals (36.27%) responded to the invitation to participate. Among the responders, 9.5% did not offer the SN procedure. However, 79.5% evaluated SNs by ultrastaging. In vulvar cancer of the midline with unilateral localized positive SN, 49.1% and 48.6% of respondents, respectively, would perform ipsilateral or bilateral inguinal lymph node dissection. Repeat SN procedure was performed by 16.2% of respondents. For isolated tumor cells (ITCs) or micrometastases, 28.1% and 60.5% of respondents, respectively, would perform inguinal lymph node dissection, whereas 19.3% and 23.8%, respectively, would opt for radiation without further surgical intervention. Notably, 50.9% of respondents would not initiate any further therapy and 15.1% would opt for expectant management. Conclusions: The majority of German hospitals implement the SN procedure. However, only 79.5% of respondents performed ultrastaging and only 28.1% were aware that ITC may affect survival in vulvar cancer. There is a need to ensure that the management of vulvar cancer follows the latest recommendations and clinical evidence. Deviations from state-of-the-art management should only be after a detailed discussion with the concerned patient.

• Publisher: MDPI AG,MDPI
• Subject: Accuracy / Biopsy / Care and treatment / Clinical medicine / Contraindications / Diagnosis / Genital cancers / Gynecology / Hospitals / Lymphatic system / Questionnaires / Sentinel lymph node biopsy / Surveys / Tumors / Vulvar cancer